Plantar fasciitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants of both sexes; aged 18 years or older; with complaints of plantar pain greater than or equal to 3 out of 10 points on the numerical pain scale for at least 3 months; reproduced with the first step in the morning and/or in activities with increased weight support, for example, standing; pain on palpation of the medial calcaneal tubercle and/or proximal plantar fascia will be included in the study; Patients who present with bilateral pain will be considered on the side with greater pain
Exclusion criteria
Exclusion criteria: Participants who have had musculoskeletal disease in the lower limbs in the last 6 months; systemic musculoskeletal disease; previous surgery on the lower limbs and spine; diabetes; pregnancy; having received corticosteroid application in the plantar fascia in the last 6 months will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction of up to one point in pain intensity on the numerical pain scale is expected at the eighth week after randomization | — |
Secondary
| Measure | Time frame |
|---|---|
| Participant satisfaction with the proposed treatment is expected to be assessed using the global treatment effect scale in the eighth week after randomization;It is expected to find a reduction in kinesiophobia, assessed using the Tampa Kinesiophobia Scale, and pain catastrophizing, assessed using the pain catastrophizing scale in the eighth week after randomization, three months and six months after randomization;Pain reduction of up to one point on the numerical pain scale and improvement in performance in three functional positions are expected at eight weeks after randomization, three months and six months after randomization;Pain reduction in the last seven days of up to one point on the numerical pain scale is expected at three and six months after randomization;Improvement in disability is expected, assessed using the patient-specific functional scale at eight weeks after randomization, three and six months after randomization;Improvement in psychosocial aspects and sleep is expected, assessed through the brief psychosocial scale in the eighth week after randomization, three months and six months after randomization | — |
Countries
Brazil
Contacts
Centro Universitário FMABC